Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 65 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/29/2008 First Published: 12/8/2006


1.		Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV, Phase III				Treatment				Active				21 and under				Other				GPOH-NB2004 EU-20661, NCT00410631


2.		Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and under				Other				RET5 NCT00186888

Last Modified: 6/17/2008 First Published: 5/23/2006


3.		Phase III Randomized Study of Doxorubicin Hydrochloride, Cyclophosphamide, Vincristine, Etoposide, and Ifosfamide With Versus Without Topotecan Hydrochloride in Patients With Newly Diagnosed Localized Ewing's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Approved-not yet active				50 and under				NCI				COG-AEWS0531 AEWS0531, NCT00334867

Last Modified: 11/30/2006 First Published: 9/15/2006


4.		Phase III Randomized Study of Ifosfamide, Vincristine, and Dactinomycin With or Without Doxorubicin in Pediatric Patients With Non-Metastatic Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 21				Other				CCLG-EPSSG-RMS-2005 EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457


5.		Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				3104000 NCT00437307

Last Modified: 9/18/2008 First Published: 7/6/2007


6.		Phase III Study of Response- and Biology-Based Combination Chemotherapy and Surgery With or Without Isotretinoin in Young Patients With Intermediate-Risk Neuroblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				12 and under				NCI				COG-ANBL0531 ANBL0531, NCT00499616


7.		Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				KTN32313R NCT00477282


8.		Hydralazine Valproate for Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				006/027/ICI NCT00532818


9.		Hydralazine Valproate for Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				006/028/DDI NCT00533299


10.		AMR PH GL 2007 CL 001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				AMR PH GL 2007 CL 001 NCT00547651

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute